PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous Transplantation

NCT00925782 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Melphalan HCL for Injection (Propylene Glycol-Free)/Alkeran for Injection
DRUG: Alkeran for Injection/Melphalan HCL for Injection (Propylene Glycol-Free)

Sponsor

Acrotech Biopharma Inc.